Recombinant listeria strain expressing heterologous antigen fusion proteins and methods of use thereof

MA40228AUndetermined Publication Date: 2017-05-24ADVAXIS INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA40228
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-07-18
Filing Date
2015-07-17
Publication Date
2017-05-24
Patent Text Reader

Abstract

Disclosed herein are recombinant nucleic acids encoding tumor antigens fused to immunogenic polypeptides and recombinant listeria strains comprising the same, methods of preparing same, and methods of inducing an immune response, and treating, inhibiting, or suppressing cancer or tumors comprising administering same.
Need to check novelty before this filing date? Find Prior Art